HomeMedicine & HealthPharmacology (continued)What is Monoclonal Antibody?
Medicine & Health·2 min·Updated Mar 15, 2026

What is Monoclonal Antibody?

Monoclonal Antibody

Quick Answer

A monoclonal antibody is a laboratory-made molecule designed to target specific proteins in the body. These antibodies are used in medicine to diagnose and treat various diseases, including cancers and autoimmune disorders.

Overview

Monoclonal antibodies are identical copies of a single type of antibody that are produced by immune cells. They are created in the lab to bind to specific targets, such as proteins on the surface of cancer cells, making them useful in both diagnosis and treatment. For example, a monoclonal antibody called trastuzumab is used to treat breast cancer by targeting the HER2 protein, which is overexpressed in some breast cancer cells. These antibodies work by recognizing and attaching to their specific targets, helping the immune system to identify and destroy harmful cells. They can also block signals that promote the growth of cancer cells or deliver drugs directly to the diseased cells. This targeted approach minimizes damage to healthy cells and enhances the effectiveness of treatments, making monoclonal antibodies a significant advancement in pharmacology. The importance of monoclonal antibodies extends beyond cancer treatment. They are also used in therapies for autoimmune diseases, such as rheumatoid arthritis, where they can help reduce inflammation and pain. Additionally, during the COVID-19 pandemic, monoclonal antibodies were developed to treat patients with severe symptoms, showcasing their versatility and potential in modern medicine.


Frequently Asked Questions

Monoclonal antibodies are made by creating a hybrid cell that combines a specific immune cell with a cancer cell. This hybrid cell, called a hybridoma, can produce large quantities of the desired antibody.
Side effects can vary depending on the specific monoclonal antibody used, but common ones include allergic reactions, fever, and fatigue. It's important for patients to discuss potential side effects with their healthcare provider.
No, monoclonal antibodies are not suitable for all types of cancer. They are effective for certain cancers that express specific proteins, and ongoing research is exploring their use in other types.